LDHA and breast carcinoma: For instance, in syngeneic immunocompetent breast cancer and melanoma models, knockdown of lactate dehydrogenase A (LDHA) in tumor cells reduced lactate production and normalized the acidic TME, which facilitated the infiltration of tumors by natural killer cells and CD8+ T cells, leading to inhibition of tumor growth [108].